Dong Ling Cao

Dong Ling Cao (Rabdosiae Rubescentis Herba) is the dried aerial parts of Rabdosia rubescens (Hemsl.) Hara, also known as Isodon rubescens (Hemsl.) H. W. Li, a perennial herbaceous plant in the family Lamiaceae (mint family). In the traditional TCM classification system, Dong Ling Cao is considered bitter and sweet in flavor with a slightly cold nature. It enters the Lung, Stomach, and Liver meridians, giving it a central role in formulas that address Toxic Heat accumulation, throat inflammation, and digestive heat patterns.

Botanical description: Rabdosia rubescens is an erect perennial herb growing 30–120 cm tall. The stems are quadrangular, finely pubescent, and green to purplish-brown in color. The leaves are opposite, petiolate, ovate to lanceolate, 3–9 cm long and 1.5–4 cm wide, with a serrated margin and a slightly rough upper surface. The leaf surface is dark green, and the lower surface is paler with visible venation. The plant produces small, purplish-blue flowers in terminal, thyrsiform panicles. The calyx is campanulate and glandular-pubescent. The entire plant has a characteristic slightly aromatic, herbaceous odor. A distinctive feature of this species is the formation of ice-like crystalline deposits on the leaf surface during winter, which gives the plant its Chinese name. The aerial parts are harvested in autumn, then dried in the shade.

Habitat and cultivation: R. rubescens is native to China and is primarily distributed in the provinces of Henan, Shanxi, Gansu, Anhui, Zhejiang, and Hubei. It grows on mountain slopes, in valleys, along forest edges, and in rocky crevices at elevations of 100–1500 meters. The plant prefers well-drained, sandy loam soils and partial shade conditions. In China, commercial cultivation has expanded significantly since the 1970s due to growing demand for pharmaceutical products. Henan Province, particularly the Jiyuan and Taihang Mountain regions, is considered the primary production area. The herb is typically harvested during the flowering period in late summer and autumn, when the diterpenoid content is at its peak.

Quality markers: The Chinese Pharmacopoeia specifies that high-quality Dong Ling Cao should have a characteristic slightly aromatic odor, a bitter taste, and adequate levels of marker compounds. The leaves should be dark green to greenish-brown, with a crisp texture and minimal stem material. The pharmacopoeia sets quality standards for the content of oridonin as a primary quality control marker. Premium-grade material is characterized by its dark green color, strong bitter taste, high oridonin content, and absence of mold, insect damage, or excessive woody stem material.

In the traditional Chinese medicine theoretical framework, Dong Ling Cao is understood in terms of its effects on specific patterns of disharmony (zheng). Because Dong Ling Cao enters the Lung, Stomach, and Liver meridians and has a bitter, sweet, and slightly cold quality, it is traditionally indicated for a range of patterns involving Toxic Heat, swelling, and pain.

Clearing heat and resolving toxicity: Dong Ling Cao is considered one of the important herbs in TCM for clearing heat and resolving toxicity. In TCM theory, Toxic Heat accumulation can manifest as sore throat, tonsillitis, and swollen, painful lymph nodes. Dong Ling Cao is traditionally used to clear this pathogenic heat from the body, using its bitter and cold nature to reduce inflammation and resolve the toxic accumulation. It is commonly used for acute pharyngitis and tonsillitis, where its heat-clearing and swelling-reducing properties are considered particularly effective.

Reducing swelling and relieving pain: Dong Ling Cao is traditionally valued for its ability to reduce swelling and relieve pain, particularly in the context of inflammatory conditions of the throat and digestive tract. In TCM practice, it is used for esophagitis, gastritis, and other conditions characterized by heat-related inflammation and tissue swelling. Its pain-relieving properties are attributed to its ability to clear heat and resolve stagnation in the affected areas. It is often combined with other heat-clearing herbs such as Jin Yin Hua and Lian Qiao to enhance its anti-inflammatory effects.

Soothing the throat and treating respiratory heat: Dong Ling Cao has a particular affinity for the Lung meridian and is widely used for throat disorders. It is traditionally indicated for sore throat, hoarseness, and difficulty swallowing, particularly when these symptoms are accompanied by heat signs such as redness, swelling, and pain. In modern TCM practice in China, it is frequently prescribed for acute and chronic pharyngitis, and it is a key ingredient in many patent medicines designed for throat discomfort. It may be combined with Ban Lan Gen and Shan Dou Gen for enhanced throat-clearing effects.

Addressing digestive heat patterns: Through its entry into the Stomach meridian, Dong Ling Cao is traditionally used for heat-related digestive disorders. Conditions such as gastritis, esophagitis, and stomach heat with burning pain are considered indications for this herb. In the TCM framework, Stomach Heat may present as burning epigastric pain, nausea, dry mouth, and a red tongue with a yellow coating. Dong Ling Cao is used to clear this heat and reduce the associated inflammation and discomfort.

Modern research context: While Dong Ling Cao was not recorded in major classical TCM texts, it has become one of the most extensively researched Chinese herbs since the 1970s. Chinese researchers first identified its potential anti-tumor properties in the 1970s, and it has since been developed into numerous pharmaceutical preparations. The herb is particularly well-known in Henan Province, where it has a long history of folk use as a remedy for sore throat and digestive complaints. An alternative name, Bing Ling Cao, references the ice-like crystal formations on the winter leaves. It is also known as Xiang Cha Cao in some regions, reflecting its traditional use as a tea substitute.

Dong Ling Cao contains a range of bioactive compounds that have been the subject of extensive pharmacological investigation. The following overview summarizes the major chemical constituents identified in the aerial parts of Rabdosia rubescens and what is currently known about them from published research.

Oridonin: Oridonin is an ent-kaurane diterpenoid and the most abundant and well-characterized constituent of Dong Ling Cao. It is the primary quality control marker specified in the Chinese Pharmacopoeia. Oridonin has been extensively studied for its anti-inflammatory, anti-tumor, and immunomodulatory properties. In pre-clinical research, oridonin has been shown to induce apoptosis in various cancer cell lines, inhibit cell proliferation, suppress NF-kappaB and PI3K/Akt signaling pathways, and modulate immune cell function. It is considered the most pharmacologically significant compound in Dong Ling Cao. However, most research has been conducted on the isolated compound rather than on whole-herb preparations, and the clinical relevance for human use is not well established.

Ponicidin: Ponicidin is another ent-kaurane diterpenoid closely related to oridonin, and it is the second most abundant diterpenoid in Dong Ling Cao. Pre-clinical studies have demonstrated that ponicidin shares many of the biological activities of oridonin, including anti-inflammatory, anti-tumor, and pro-apoptotic effects. Research has shown that ponicidin can inhibit the growth of cancer cell lines and induce cell cycle arrest. While less studied than oridonin, ponicidin is considered an important contributor to the overall pharmacological profile of Dong Ling Cao.

Rubescensin A and B: Rubescensin A and B are additional ent-kaurane diterpenoids isolated fromR. rubescens. These compounds have been studied for their biological activities, with research indicating cytotoxic effects against certain cancer cell lines. Rubescensin A, in particular, has shown promise in pre-clinical studies for its ability to induce apoptosis and inhibit tumor growth. These compounds represent the diverse diterpenoid chemistry that characterizes Dong Ling Cao.

Lasiodin: Lasiodin is a diterpenoid glycoside identified in R. rubescens. It has been studied for its potential anti-tumor and anti-inflammatory properties. While less abundant than oridonin, lasiodin contributes to the overall chemical diversity of the herb and may play a role in its traditional pharmacological effects.

Flavonoids and phenolic acids: Dong Ling Cao contains various flavonoid compounds and phenolic acids that have been identified through phytochemical analysis. These include luteolin, apigenin, and their glycosides, as well as caffeic acid and chlorogenic acid derivatives. The flavonoids have been studied for their antioxidant and anti-inflammatory properties, while the phenolic acids contribute to the herb's overall antioxidant capacity. These non-diterpenoid constituents may work synergistically with the major diterpenoids to produce the herb's overall pharmacological effects.

The compounds listed above are chemical constituents identified through phytochemical analysis. Their pharmacological activities described are based on pre-clinical studies (animal models, in-vitro experiments) and do not represent confirmed clinical effects in humans.

Dong Ling Cao is a relatively modern herb in the TCM pharmacopoeia and is not found in classical formulas from the traditional TCM canon. Instead, it has been widely incorporated into modern pharmaceutical preparations and contemporary formula compositions. Below are examples of its primary applications in modern herbal products.

The following section summarizes published pharmacological and pre-clinical research. Unless explicitly stated otherwise, the studies cited are animal models, in-vitro experiments, or mechanistic research — not human clinical trials. These findings should not be interpreted as evidence for clinical efficacy or as a basis for self-treatment.

Anti-tumor mechanisms of oridonin: Oridonin, the principal diterpenoid of Dong Ling Cao, has been the subject of extensive anti-cancer research. Pre-clinical studies have demonstrated that oridonin can induce apoptosis in cancer cells through multiple mechanisms, including activation of the mitochondrial apoptotic pathway, modulation of Bcl-2 family proteins, generation of reactive oxygen species, and cell cycle arrest. Li et al. (2024) reported that oridonin inhibited the proliferation and promoted apoptosis of gastric cancer cells through the PI3K/Akt signaling pathway (PMID: 38516032). Zhang et al. (2024) demonstrated that oridonin exerted anti-tumor effects in esophageal cancer models by targeting NF-kappaB and MAPK signaling cascades. These findings are mechanistically interesting but are derived from cell culture and animal models.

Anti-inflammatory effects: Wang et al. (2023) investigated the anti-inflammatory effects of oridonin in lipopolysaccharide-stimulated macrophage models and found that it significantly reduced the production of pro-inflammatory cytokines (TNF-alpha, IL-1beta, and IL-6) through suppression of the NF-kappaB signaling pathway. Liu et al. (2024) reported that R. rubescens extract attenuated inflammation in a murine model of chronic pharyngitis by downregulating inflammatory mediators and reducing tissue damage. Chen et al. (2025) demonstrated that ponicidin, the second major diterpenoid, exerted anti-inflammatory effects through inhibition of the NLRP3 inflammasome pathway. These pre-clinical findings suggest potential anti-inflammatory mechanisms but do not constitute evidence for clinical efficacy.

Antimicrobial activity: Zhao et al. (2023) evaluated the antimicrobial properties of R. rubescens essential oil and its major constituents against common respiratory pathogens, finding inhibitory activity against several bacterial species associated with pharyngitis and tonsillitis. The essential oil of R. rubescens has also shown antifungal properties in pre-clinical screening studies. However, the antimicrobial concentrations used in laboratory studies may not be achievable through standard oral dosing of whole-herb preparations, and the clinical relevance of these findings remains uncertain.

Hepatoprotective and immunomodulatory effects: Emerging research has explored the hepatoprotective potential of Dong Ling Cao constituents. Sun et al. (2024) reported that oridonin exhibited protective effects against chemically induced liver injury in animal models through antioxidant and anti-apoptotic mechanisms. Li et al. (2025) demonstrated that R. rubescens polysaccharides modulated immune cell function in pre-clinical models, suggesting potential immunomodulatory properties that may contribute to the herb's traditional use for immune-related conditions.

What the research does NOT show: Despite promising pre-clinical signals, the research on Dong Ling Cao and its active compounds does NOT demonstrate conclusive clinical efficacy for any specific disease in humans. There is no robust evidence from large-scale, randomized, placebo-controlled clinical trials that Dong Ling Cao can treat, cure, or prevent cancer, infectious diseases, or any other medical condition. The translation from animal models to human clinical relevance is uncertain. This page does not endorse Dong Ling Cao as a treatment for any condition.

Important: All pharmacological effects described above are based on pre-clinical studies (animal models, in-vitro experiments, or mechanistic research). They do not constitute evidence of clinical efficacy in humans. This section is provided for educational context and should not be used as a basis for treatment decisions.

General safety profile: Dong Ling Cao is widely used in modern Chinese clinical practice and is generally considered to have a favorable safety profile when used appropriately at standard doses. However, like all herbal products, it is not free of risk. The information below reflects what is currently known from published literature, pharmacopoeial standards, and clinical experience.

Spleen-Stomach deficiency-cold: In traditional TCM theory, Dong Ling Cao is bitter and slightly cold in nature. Individuals with Spleen-Stomach deficiency-cold — characterized by poor appetite, loose stools, abdominal coldness, and a pale tongue with white coating — should use Dong Ling Cao with caution, as its cold nature may further weaken digestive function. Prolonged use or high doses may theoretically worsen these patterns. This caution is based on traditional TCM theory rather than modern clinical evidence.

Qi deficiency: Individuals with Qi deficiency patterns — presenting as fatigue, shortness of breath, spontaneous sweating, and a weak pulse — should use Dong Ling Cao with caution. The herb's toxicity-resolving and cold properties may be too harsh for a weakened constitution and could potentially further deplete Qi. In TCM practice, Dong Ling Cao is typically combined with Qi-tonifying herbs when used in patients with underlying deficiency.

Pregnancy and lactation: The safety of Dong Ling Cao during pregnancy has not been adequately established through clinical studies. Given its cold and bitter nature and its potential pharmacological effects, its use during pregnancy is generally not recommended. Self-administration of Dong Ling Cao products during pregnancy should be avoided. Dong Ling Cao should only be used during pregnancy under the direct supervision of a qualified healthcare professional if the potential benefits clearly outweigh the risks.

Injection preparations: Dong Ling Cao injectable preparations carry additional risks compared to oral formulations, including potential allergic reactions and injection-site reactions. These preparations should only be administered in clinical settings under qualified medical supervision. Reported adverse reactions to injectable preparations have included allergic responses, dizziness, and gastrointestinal discomfort. The injectable format is restricted to hospital use in China.

Drug interactions: Pre-clinical data suggest that oridonin and other constituents of Dong Ling Cao may affect hepatic cytochrome P450 enzyme activity, which could theoretically alter the metabolism of drugs processed through these pathways. There is also a theoretical risk of additive interactions with immunosuppressive medications or anticoagulants due to the herb's potential immunomodulatory effects. Clinical interaction data for whole-herb Dong Ling Cao are very limited. Consult a qualified healthcare professional before combining Dong Ling Cao with any prescription medications.

This platform provides educational information about traditional Chinese medicine herbs. It does not recommend, endorse, or prescribe the use of Dong Ling Cao or any other herbal product for the treatment of any medical condition. All decisions regarding herbal use should be made in consultation with a qualified healthcare provider.